GlassScriptPhysician profile
Julie E Chang
NPI 1679524078
$17,080.79
in general payments reported to CMS, 2019-2025
18 companies · $5,025 in 2025
The $5,025 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,352 · 2021: $1,650 · 2022: $5,862 · 2023: $845 · 2024: $1,347 · 2025: $5,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,825 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $272 · Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,825.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $272.25 |
| Food and Beverage | $120.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,575.00 | 2022-2024 | Venclexta |
| Astrazeneca Pharmaceuticals LP | $3,569.42 | 2024-2025 | Calquence |
| Incyte Corporation | $2,670.00 | 2022-2025 | |
| F. Hoffmann-La Roche Ag | $2,351.56 | 2019 | |
| Beigene, LTD. | $1,650.00 | 2021 | |
| Beigene USA, INC. | $1,650.00 | 2022 | |
| Genentech USA, INC. | $1,375.00 | 2022 | |
| Taiho Oncology, INC. | $117.85 | 2023-2024 | |
| Adc Therapeutics America, INC. | $100.38 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.58 | 2022 |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.